Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
Go back to Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs| (NASDAQ: ASMB) | Delayed: 20.09 -0.48 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.57 | 52 Week High | $14.50 | |||
| Open | $20.63 | 52 Week Low | $4.33 | |||
| Day High | $20.63 | P/E | N/A | |||
| Day Low | $19.94 | EPS | $0.00 | |||
| Volume | 167,736 | |||||



